Intech Investment Management LLC Purchases 2,460 Shares of National Health Investors, Inc. $NHI

Intech Investment Management LLC boosted its position in shares of National Health Investors, Inc. (NYSE:NHIFree Report) by 8.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,038 shares of the real estate investment trust’s stock after acquiring an additional 2,460 shares during the period. Intech Investment Management LLC’s holdings in National Health Investors were worth $2,176,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Smartleaf Asset Management LLC increased its position in shares of National Health Investors by 49.8% during the first quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust’s stock worth $33,000 after purchasing an additional 147 shares in the last quarter. Assetmark Inc. grew its stake in National Health Investors by 19.0% during the 2nd quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock worth $65,000 after buying an additional 148 shares during the last quarter. NewEdge Advisors LLC grew its stake in National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after buying an additional 345 shares during the last quarter. Jupiter Asset Management Ltd. acquired a new position in National Health Investors during the 1st quarter valued at about $206,000. Finally, Monument Capital Management purchased a new stake in National Health Investors in the second quarter valued at about $252,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company boosted their price target on National Health Investors from $76.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 27th. Cantor Fitzgerald started coverage on shares of National Health Investors in a research report on Wednesday, October 1st. They set an “overweight” rating and a $90.00 target price on the stock. Truist Financial upped their price target on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research note on Friday, August 15th. National Bankshares set a $90.00 price objective on shares of National Health Investors in a research note on Wednesday, October 1st. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of National Health Investors in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, National Health Investors presently has an average rating of “Buy” and an average target price of $84.83.

Check Out Our Latest Stock Report on National Health Investors

National Health Investors Stock Performance

NHI opened at $78.31 on Friday. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75. National Health Investors, Inc. has a 12-month low of $65.13 and a 12-month high of $80.56. The firm has a 50 day moving average of $76.64 and a two-hundred day moving average of $74.49. The firm has a market capitalization of $3.73 billion, a PE ratio of 25.02, a P/E/G ratio of 3.31 and a beta of 0.74.

National Health Investors (NYSE:NHIGet Free Report) last released its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, beating the consensus estimate of $1.24 by $0.08. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The business had revenue of $83.36 million for the quarter, compared to the consensus estimate of $85.66 million. During the same period in the prior year, the firm earned $1.03 EPS. The business’s revenue for the quarter was down 1.8% on a year-over-year basis. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 4.7%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is currently 116.09%.

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Further Reading

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHIFree Report).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.